Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Journal of Pharmaceutical Sciences
|
May 1, 1997
Isolation and structure elucidation of the major degradation products of cefaclor formed under aqueous acidic conditions
S W Baertschi, D E Dorman, J L Occolowitz, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1997
Isolation and structure elucidation of the major degradation products of cefaclor in the solid state
D E Dorman, L J Lorenz, J L Occolowitz, et al.
The Journal of Antibiotics
|
April 1, 1983
Elucidation of structure of novel macrolide antibiotics produced by mutant strains of Streptomyces fradiae
H A Kirst, G M Wild, R H Baltz, et al.
The Journal of Antibiotics
|
May 1, 1985
The structure of A201A, a novel nucleoside antibiotic
H A Kirst, D E Dorman, J L Occolowitz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 1, 1997
Metabolism and disposition of the antifolate LY231514 in mice and dogs
J M Woodland, C J Barnett, D E Dorman, et al.
Journal of Medicinal Chemistry
|
May 1, 1980
Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists
N J Bach, E C Kornfeld, N D Jones, et al.
The Journal of Antibiotics
|
April 1, 1975
Structure of althiomycin
H A Kirst, E F Szymanski, D E Dorman, et al.
Journal of Pharmaceutical Sciences
|
October 1, 1993
Aqueous acidic degradation of the carbacephalosporin loracarbef
M J Skibic, K W Taylor, J L Occolowitz, et al.
Journal of Pharmaceutical Sciences
|
June 22, 2000
The degradation of the antitumor agent gemcitabine hydrochloride in an acidic aqueous solution at pH 3.2 and identification of degradation products
P J Jansen, M J Akers, R M Amos, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1993
Disposition of zatosetron, a serotonin (5-HT3) receptor antagonist, in humans
P M Franz, E L Mattiuz, B L Hatcher, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Journal of Pharmaceutical Sciences
|
May 1, 1997
Isolation and structure elucidation of the major degradation products of cefaclor formed under aqueous acidic conditions
S W Baertschi, D E Dorman, J L Occolowitz, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1997
Isolation and structure elucidation of the major degradation products of cefaclor in the solid state
D E Dorman, L J Lorenz, J L Occolowitz, et al.
The Journal of Antibiotics
|
April 1, 1983
Elucidation of structure of novel macrolide antibiotics produced by mutant strains of Streptomyces fradiae
H A Kirst, G M Wild, R H Baltz, et al.
The Journal of Antibiotics
|
May 1, 1985
The structure of A201A, a novel nucleoside antibiotic
H A Kirst, D E Dorman, J L Occolowitz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 1, 1997
Metabolism and disposition of the antifolate LY231514 in mice and dogs
J M Woodland, C J Barnett, D E Dorman, et al.
Journal of Medicinal Chemistry
|
May 1, 1980
Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists
N J Bach, E C Kornfeld, N D Jones, et al.
The Journal of Antibiotics
|
April 1, 1975
Structure of althiomycin
H A Kirst, E F Szymanski, D E Dorman, et al.
Journal of Pharmaceutical Sciences
|
October 1, 1993
Aqueous acidic degradation of the carbacephalosporin loracarbef
M J Skibic, K W Taylor, J L Occolowitz, et al.
Journal of Pharmaceutical Sciences
|
June 22, 2000
The degradation of the antitumor agent gemcitabine hydrochloride in an acidic aqueous solution at pH 3.2 and identification of degradation products
P J Jansen, M J Akers, R M Amos, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1993
Disposition of zatosetron, a serotonin (5-HT3) receptor antagonist, in humans
P M Franz, E L Mattiuz, B L Hatcher, et al.
Page
of 3